Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EBT (2016 - 2025)

Historic EBT for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $22.6 million.

  • Lemaitre Vascular's EBT rose 5513.02% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.9 million, marking a year-over-year increase of 2720.84%. This contributed to the annual value of $56.9 million for FY2024, which is 4407.85% up from last year.
  • Latest data reveals that Lemaitre Vascular reported EBT of $22.6 million as of Q3 2025, which was up 5513.02% from $18.1 million recorded in Q2 2025.
  • Over the past 5 years, Lemaitre Vascular's EBT peaked at $22.6 million during Q3 2025, and registered a low of $5.5 million during Q2 2022.
  • For the 5-year period, Lemaitre Vascular's EBT averaged around $11.2 million, with its median value being $10.3 million (2023).
  • As far as peak fluctuations go, Lemaitre Vascular's EBT soared by 11932.03% in 2021, and later tumbled by 4693.45% in 2022.
  • Lemaitre Vascular's EBT (Quarter) stood at $7.9 million in 2021, then decreased by 1.35% to $7.8 million in 2022, then surged by 45.08% to $11.3 million in 2023, then rose by 23.94% to $14.0 million in 2024, then surged by 60.99% to $22.6 million in 2025.
  • Its EBT stands at $22.6 million for Q3 2025, versus $18.1 million for Q2 2025 and $14.2 million for Q1 2025.